Aspira Pathlab & Diagnostics Share Price

30.00

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 21-Sep-2019 21-Aug-2019 - -
AGM 21/09/2019 In relation to the proposed fund raising by preferential allotment of equity shares by the Aspira Pathlab & Diagnostics Limited (the Company). In furtherance to our letter dated July 31, 2019, with respect to the issuance of Equity Shares on a preferential basis, we wish to inform you that the board of directors of the Company (the Board) at its meeting held on August 21, 2019, subject to the approval of the shareholders of the Company, has approved the issue and allotment of up to 38,00,000 (Thirty Eight Lakhs) Equity Shares of face value of INR 10/- each, at an issue price Rs. 26 (Rupees Twenty Six) including premium of Rs. 16 (Rupees Sixteen) to strategic investors not forming part of promoter or promoter group, on a preferential basis, on terms and conditions as approved by the Board. We would also like to inform that an Annual General Meeting of the Members of the Company will be held on 21th September, 2019 for seeking their approval for the above issue of shares. This is to inform you that the 46th Annual General Meeting of the Members of the Company is scheduled to be held on Saturday, September 21, 2019 at 11.00 am at Lantana Hall, Ghatkopar Jolly Gymkhana, Jugaldas Modi Marg, (Kirol Road), Ghatkopar (West), Mumbai- 400086, Maharashtra. Pursuant to Regulation 34 (1) of Listing Regulations, we enclose herewith the Annual Report of the Company for the Financial Year 2018-19, including the Notice of the 46th Annual General Meeting scheduled to be held on September 21, 2019. The same is also available on the website of the Company at the following weblink : https://www.aspiradiagnostics.com/wp-content/uploads/2019/08/Annual-Report-2018-19.pdf The Company will provide to its members the facility to cast their vote(s) on all resolutions set out in the Notice by electronic means (e-voting). The e-voting communication giving instructions for e-voting, being sent along with the integrated Annual Report, is also attached. (As Per BSE Announcement Dated On 28/08/2019) We wish to inform you that the 46th Annual General Meeting of the Members of the Company was held on Saturday, September 21, 2019 at 11.00 am at Lantana Hall, Ghatkopar Jolly Gymkhana, Jugaldas Modi Marg, (Kirol Road), Ghatkopar (West), Mumbai- 400086, Maharashtra. Pursuant to Regulation 30 read with Para A of Part A in schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing a summary of the proceedings of the Companys Forty Sixth Annual General Meeting. We request you to disseminate the above information on your website. (As Per BSE Announcement Dated on 21/09/2019) We wish to inform you that the 46th Annual General Meeting (AGM) of the Company was held on Saturday, September 21, 2019 at Lantana Hall, Ghatkopar Jolly Gymkhana, Jugaldas Modi Marg, (Kirol Road), Ghatkopar (West), Mumbai- 400086, Maharashtra. In terms of the Consolidated Report of the Scrutinizer, Mr. S.K. Pandey, Practicing Company Secretaries, on the remote e-voting and voting at the AGM through Poll conducted, all the Resolutions set out in the Notice of the 46th AGM are validly passed with the requisite majority. In accordance with the Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the consolidated voting results of the business transacted at the AGM and the consolidated report of scrutinizers are enclosed as Annexure I and Annexure II. Aspira Pathlab & Diagnostics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated 23.09.2019)